Owner Chugai Seiyaku Kabushiki Kaisha Matsushima , K. Hashimoto , S.

Inventors Hashimoto, Shinichi; Matsushima, Kouji; Ojima, Kazuyuki; Yoshida, Kenji; Hirata, Yuichi; Tsuchiya, Masayuki

Agent Spruson & Ferguson

Pub. Number AU-B-2004276646

PCT Pub. Number WO2005/030955

Priority 2003-338331 29.09.03 JP

Filing date 29 September 2004

Wipo publication date 7 April 2005

Acceptance publication date 12 July 2012

C12N 15/00 Mutation or genetic engineering

A61K 31/00

A61P 1/16 Drugs for disorders of the alimentary tract or the digestive system

A61P 11/06 Drugs for disorders of the respiratory system

A61P 31/12 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 Antineoplastic agents

A61P 37/04 Drugs for immunological or allergic disorders

A61P 37/06 Drugs for immunological or allergic disorders

A61P 37/08 Drugs for immunological or allergic disorders

C07K 14/705 Peptides having more than 20 amino acids

C12N 1/15 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/19 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

C12N 1/21 Micro-organisms, e.g. protozoa - modified by introduction of foreign genetic material

G01N 33/564 Investigating or analysing materials by specific methods not covered by groups - for pre-existing immune complex or autoimmune disease

G01N 33/566 Investigating or analysing materials by specific methods not covered by groups - using specific carrier or receptor proteins as ligand binding reagent